Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Wipperman, Matthew F ^a,b   Fitzgerald, Daniel W ^b,c   Juste, Marc Antoine Jean ^c   Taur, Ying ^a   Namasivayam, Sivaranjani ^d   Sher, Alan ^d   Bean, James M ^a,b   Bucci, Vanni ^a,e   Glickman, Michael S ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Centers Institute of Infectious Diseases and Reproductive Health   (Haïti)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF MASSACHUSETTS DARTMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; COMBINATION DRUG THERAPY; CROSS-SECTIONAL STUDY; DRUG EFFECT; DYSBIOSIS; FEMALE; GENETICS; HAITI; HUMAN; INTESTINE FLORA; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; DYSBIOSIS; FEMALE; GASTROINTESTINAL MICROBIOME; HAITI; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 85029111948     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-10346-6     Document Type: Article

References (43)

1. Global Tuberculosis Report (World Health Organization, 2016).
2. Nathan, C. What can immunology contribute to the control of the world's leading cause of death from bacterial infection? Immunol Rev 264, 2-5, doi:10. 1111/imr. 12277 (2015).
3. Abel, L., El-Baghdadi, J., Bousfiha, A. A., Casanova, J. L. & Schurr, E. Human genetics of tuberculosis: a long and winding road. Philos Trans R Soc Lond B Biol Sci 369, 20130428, doi:10. 1098/rstb. 2013. 0428 (2014).
4. Honda, K. & Littman, D. R. The microbiota in adaptive immune homeostasis and disease. Nature 535, 75-84, doi:10. 1038/ nature18848 (2016).
5. Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446-450, doi:10. 1038/nature12721 (2013).
6. Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451-455, doi:10. 1038/nature12726 (2013).
7. Trompette, A. et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20, 159-166, doi:10. 1038/nm. 3444 (2014).
8. Arrieta, M. C. et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 7, 307ra152, doi:10. 1126/scitranslmed. aab2271 (2015).
9. Segal, L. N. et al. Anaerobic Bacterial Fermentation Products Increase Tuberculosis Risk in Antiretroviral-Drug-Treated HIV Patients. Cell Host Microbe 21, 530-537, e534, doi:10. 1016/j. chom. 2017. 03. 003 (2017).
10. Moya, A. & Ferrer, M. Functional Redundancy-Induced Stability of Gut Microbiota Subjected to Disturbance. Trends Microbiol 24, 402-413, doi:10. 1016/j. tim. 2016. 02. 002 (2016).
11. Becattini, S., Taur, Y. & Pamer, E. G. Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. Trends Mol Med 22, 458-478, doi:10. 1016/j. molmed. 2016. 04. 003 (2016).
12. Brismar, B., Edlund, C., Malmborg, A. S. & Nord, C. E. Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother 34, 481-483 (1990).
13. Dethlefsen, L., Huse, S., Sogin, M. L. & Relman, D. A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6, e280, doi:10. 1371/journal. pbio. 0060280 (2008).
14. Hernandez, E. et al. Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity. Gut Microbes 4, 306-315, doi:10. 4161/gmic. 25321 (2013).
15. Theriot, C. M. et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun 5, 3114, doi:10. 1038/ncomms4114 (2014).
16. Taur, Y. et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 55, 905-914, doi:10. 1093/cid/cis580 (2012).
17. Dethlefsen, L. & Relman, D. A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 108(Suppl 1), 4554-4561, doi:10. 1073/pnas. 1000087107 (2011).
18. Namasivayam, S. et al. Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy. Microbiome 5, 71, doi:10. 1186/s40168-017-0286-2 (2017).
19. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq. 2. Genome Biol 15, 550, doi:10. 1186/s13059-014-0550-8 (2014).
20. Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol 12, R60, doi:10. 1186/gb-2011-12-6-r60 (2011).
21. Zaborin, A. et al. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness. MBio 5, e01361-01314, doi:10. 1128/mBio. 01361-14 (2014).
22. Abubucker, S. et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput Biol 8, e1002358, doi:10. 1371/journal. pcbi. 1002358 (2012).
23. Jernberg, C., Lofmark, S., Edlund, C. & Jansson, J. K. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 1, 56-66, doi:10. 1038/ismej. 2007. 3 (2007).
24. Taur, Y. & Pamer, E. G. Harnessing microbiota to kill a pathogen: Fixing the microbiota to treat Clostridium difficile infections. Nat Med 20, 246-247, doi:10. 1038/nm. 3492 (2014).
25. Shen, Y. et al. Outer membrane vesicles of a human commensal mediate immune regulation and disease protection. Cell Host Microbe 12, 509-520, doi:10. 1016/j. chom. 2012. 08. 004 (2012).
26. Schirmer, M. et al. Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity. Cell 167, 1897, doi:10. 1016/j. cell. 2016. 11. 046 (2016).
27. Tan, T. G. et al. Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice. Proc Natl Acad Sci USA 113, E8141-E8150, doi:10. 1073/pnas. 1617460113 (2016).
28. Verver, S. et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med 171, 1430-1435, doi:10. 1164/rccm. 200409-1200OC (2005).
29. Glynn, J. R. et al. High rates of recurrence in HIV-infected and HIV-uninfected patients with tuberculosis. J Infect Dis 201, 704-711, doi:10. 1086/650529 (2010).
30. United, S. Health Insurance Portability and Accountability Act of 1996. Public Law 104-191. US Statut Large 110, 1936-2103 (1996).
31. Harris, P. A. et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42, 377-381, doi:10. 1016/j. jbi. 2008. 08. 010 (2009).
32. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227, doi:10. 1038/nature11053 (2012).
33. Edgar, R. C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10, 996-998, doi:10. 1038/ nmeth. 2604 (2013).
34. Haas, B. J. et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res 21, 494-504, doi:10. 1101/gr. 112730. 110 (2011).
35. Camacho, C. et al. BLAST+: architecture and applications. BMC Bioinformatics 10, 421, doi:10. 1186/1471-2105-10-421 (2009).
36. Geer, L. Y. et al. The NCBI BioSystems database. Nucleic Acids Res 38, D492-496, doi:10. 1093/nar/gkp858 (2010).
37. McDonald, D. et al. The Biological Observation Matrix (BIOM) format or: how I learned to stop worrying and love the ome-ome. Gigascience 1, 7, doi:10. 1186/2047-217X-1-7 (2012).
38. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria, 2016).
39. McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One 8, e61217, doi:10. 1371/journal. pone. 0061217 (2013).
40. Wickham, H. ggplot2: Elegant Graphics for Data Analysis. (Springer Publishing Company, Incorporated, 2009).
41. Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114-2120, doi:10. 1093/bioinformatics/btu170 (2014).
42. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat Methods 9, 357-359, doi:10. 1038/nmeth. 1923 (2012).
43. Truong, D. T. et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods 12, 902-903, doi:10. 1038/nmeth. 3589 (2015).